How is the Pyxis Oncology Inc today?

The Pyxis Oncology Inc today is trading in the down by -1.64% at 1.20.

How has Pyxis Oncology Inc performed historically?

The Pyxis Oncology Inc is currently trading down -1.64% on an intraday basis in the past week the index fell -3.23%. The index has been up 8.11% in the past quarter and fell -68.83% in the past year. You can view this in the overview section.

What is Pyxis Oncology Inc Annual Net Profit?

Pyxis Oncology Inc Annual Net Profit fell 4.8% in the last year to $77.33 M. Its sector's average net profit growth for the last fiscal year was -13.89%.

What is Pyxis Oncology Inc Price to Earning Ratio?

Pyxis Oncology Inc Price to Earning Ratio is -0.78, which is negative.

What is Pyxis Oncology Inc Stock Price?

Pyxis Oncology Inc Stock Price fell 68.83% and underperformed its sector by 93.64% in the past year.

What is Pyxis Oncology Inc Quarterly Net profit?

Pyxis Oncology Inc Quarterly Net profit fell 549.82% YoY to $21.16 M. Its sector's average net profit growth YoY for the quarter was -238.55%.

What is Pyxis Oncology Inc Debt to Equity Ratio?

Pyxis Oncology Inc Debt to Equity Ratio of 0.17 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Pyxis Oncology Inc Return on Equity(ROE)?

Pyxis Oncology Inc Return on Equity(ROE) for the last financial year was -62.75%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Pyxis Oncology Inc Mutual Fund Holding?

Pyxis Oncology Inc Mutual Fund Holding decreased by 1.46% in the last quarter to 16.93.

What is Pyxis Oncology Inc Institutional Holding?

Pyxis Oncology Inc Institutional Holding decreased by 1.36% in the last quarter to 51.32.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
PYXIS ONCOLOGY INC

Pyxis Oncology Inc XNAS: PYXS

Pyxis Oncology Inc Live Share Price Today, Share Analysis and Chart

Name: Pyxis Oncology Inc: Is Infosys Ltd. worth buying?
Item: Pyxis Oncology Inc
Rating: 1.25816675
Author: Trendlyne DVM scores

about

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective...

1.20 -0.02 (-1.64%)

77.74% Fall from 52W High

347.4K

XNAS Volume

XNAS 13 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Pyxis Oncology Inc is on 18 Jun 2025 for the purpose of Pyxis Oncology Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

13.2 / 100

Technically Neutral

37.2 / 100

1Yr Price target upside is 417%

5 analysts

Pyxis Oncology Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Pyxis Oncology Inc Live Share Price Today, Share Analysis and Chart

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective...

77.74% Fall from 52W High

SWOT Analysis

Pyxis Oncology Inc Live Price Chart

Pyxis Oncology Inc FAQ

How is Pyxis Oncology Inc today?

Pyxis Oncology Inc today is trading in the red, and is down by -1.64% at 1.20.

How has Pyxis Oncology Inc performed historically?

Pyxis Oncology Inc is currently trading down -1.64% on an intraday basis. In the past week the stock fell -3.23%. stock has been up 8.11% in the past quarter and fell -68.83% in the past year. You can view this in the overview section.